ICAM1 and lung carcinoma: THC, CBD, and R(+)‐methanandamide (an endocannabinoid analogue) have been shown to promote the expression of ICAM‐1 on lung cancer cell lines A549, H460, and metastatic cells derived from a lung cancer patient.